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Background: Hypoxia induces the epithelial-mesenchymal transition, EMT, to promote cancer metastasis. In addition to
transcriptional regulation mediated by hypoxia-inducible factors, HIFs, other epigenetic mechanisms of gene regulation,
such as histone modifications and DNA methylation, are utilized under hypoxia. However, whether DNA demethylation
mediated by TET1, a DNA dioxygenase converting 5-methylcytosine, 5mC, into 5-hydroxymethylcytosine, 5hmC, plays a
role in hypoxia-induced EMT is largely unknown.
Results: We show that TET1 regulates hypoxia-responsive gene expression. Hypoxia/HIF-2α regulates the expression of
TET1. Knockdown of TET1 mitigates hypoxia-induced EMT. RNA sequencing and 5hmC sequencing identified the set of
TET1-regulated genes. Cholesterol metabolic process genes are among the genes that showed high prevalence
and statistical significance. We characterize one of the genes, INSIG1 (insulin induced gene 1), to confirm its
expression and the 5hmC levels in its promoter. Knockdown of INSIG1 also mitigates hypoxia-induced EMT.
Finally, TET1 is shown to be a transcriptional co-activator that interacts with HIF-1α and HIF-2α to enhance their
transactivation activity independent of its enzymatic activity. TET1 acts as a co-activator to further enhance the
expression of INSIG1 together with HIF-2α. We define the domain in HIF-1α that interacts with TET1 and map the
domain in TET1 that confers transactivation to a 200 amino acid region that contains a CXXC domain. The TET1
catalytically inactive mutant is capable of rescuing hypoxia-induced EMT in TET1 knockdown cells.
Conclusions: These findings demonstrate that TET1 serves as a transcription co-activator to regulate hypoxia-responsive
gene expression and EMT, in addition to its role in demethylating 5mC.Background
Cells develop various mechanisms to cope with hypoxia and
survive [1,2]. Hypoxia induces the epithelial-mesenchymal
transition (EMT) to promote cancer metastasis [3-6]. In
addition to transcriptional regulation mediated by hypoxia-
inducible factors (HIFs), other epigenetic mechanisms of
gene regulation, such as histone modifications and DNA
methylation, are utilized under hypoxia [7-9]. Certain chro-
matin changes have been observed during EMT. For ex-
ample in Snail-induced EMT, loss of H3K4Me3, H3K4Ac,
and H3K27Ac, and gain of H3K27Me3 were observed for
genes repressed, whereas gain of H3K4Me3, H3K4Me1, and
loss of H3K27Me3 were observed for genes activated [10].* Correspondence: wukj@mail.cmu.edu.tw
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unless otherwise stated.Other specific chromatin changes have also been observed
during hypoxia or TGF-β-induced EMT [11,12].
DNA demethylation is recently shown to be an import-
ant epigenetic mechanism that regulates gene expression
due to the discovery of TET (ten-eleven translocation) en-
zymes that demethylate DNA [13,14]. TET enzymes have
been shown to convert 5-methylcytosine (5mC) to 5-
hydroxymethylcytosine (5hmC) to regulate gene expression
[13-15]. Tet proteins can also convert 5-methylcytosine to
5-formylcytosine and 5-carboxycytosine [16,17]. Tet1 and
Tet2 are regulated by Oct4 during somatic cell reprogram-
ming into induced pluripotent stem cells [18]. However,
other mechanisms regulating expression of Tet1 genes re-
main largely unknown.
In this report, we explored the mechanism of TET1
regulation by hypoxia. The role TET1 in regulating the
process of EMT induced by hypoxia was investigated. The
set of genes that was regulated by TET1 under hypoxia. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Tsai et al. Genome Biology 2014, 15:513 Page 2 of 13
http://genomebiology.com/2014/15/11/513and their role in hypoxia-induced EMT were delineated.
Finally, we showed the extra role of TET1 in serving as a
transcription co-activator. These results provide a fresh
insight into regulation of hypoxia-responsive gene expres-
sion by TET1 and further expand the role of TET1.
Results and discussion
Hypoxia/HIF-2α activates TET1 expression and knockdown
of TET1 mitigates hypoxia-induced epithelial-mesenchymal
transition
TET enzymes have been shown to convert 5mC to 5hmC
to regulate gene expression [13-15]. In spite of the various
epigenetic mechanisms demonstrated to regulate hypoxia-
responsive gene expression [8,9], the role of TET enzymes
and DNA demethylation in regulating hypoxia-responsive
genes remain largely unknown. We tested whether TET1
could be regulated by hypoxia to mediate hypoxia-regulatedFigure 1 Activation of TET1 by hypoxia/HIF-2α and knockdown of TE
(a) Western blot analysis showed the activation of TET1 by hypoxia. N: normo
using western blot analysis. (c) Knockdown of HIF-2α abolished the activa
activation of TET1 proximal promoter by HIF-2α. The asterisk (*) indicates
transfections. pXP2-Tet1-381 or pXP2-Tet1-158 vector alone was used as t
of triplicate luciferase activity. (e) Knockdown of TET1 mitigated the procgene expression. Exposure of various cell lines to hyp-
oxia showed the activation of TET1 mRNA expression
(Additional file 1a). Western blot analysis confirmed
the upregulation of TET1 protein levels by hypoxia
(Figure 1a). Overexpression of HIF-2α, but not HIF-1α,
activated the expression of TET1 (Figure 1b and data
not shown). Knockdown of HIF-2α abolished the acti-
vation of TET1 under hypoxia in two different cell lines
(Figure 1c and Additional file 1b and c), indicating that
HIF-2α was the major regulator of TET1 expression
under hypoxia. We further identified the region in the
proximal promoter of TET1 gene that responded to
hypoxia and HIF-2α. Reporter gene assay showed that
the promoter region (-381 to +17 bp upstream of the
transcription start site, TSS) of the TET1 gene was acti-
vated by hypoxia/HIF-2α (Figure 1d and Additional file 2).
The hypoxia response region was further narrowed downT1 mitigated hypoxia-induced epithelial-mesenchymal transition.
xia; H: hypoxia. (b) Overexpression of HIF-2α activated TET1 expression
tion of TET1 by hypoxia. (d) Reporter gene assays showed the
statistical significance (P <0.05) between experimental and control
he control transfection. Error bars indicate standard deviations (s.d.)
ess of hypoxia-induced EMT.
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construct containing the promoter region of -91 to +17 bp
upstream of the TSS did not respond to hypoxia/HIF-2α
stimulation (data not shown), further narrowing down the
hypoxia/HIF-2α responsive region to -158 to -91 bp up-
stream of the TSS of TET1 gene. Chromatin immunopre-
cipitation experiments showed that HIF-2α directly bound
to the proximal promoter region (Additional file 1d). Posi-
tive control also showed that HIF-2α bound to the pro-
moter region of WDR5 gene (Additional file 1d) [11]. All
these results indicate the direct regulation of TET1 gene
expression by HIF-2α.
Since EMT is induced by hypoxia to promote tumor
metastasis [3-6], we tested whether TET1 plays a sig-
nificant role in hypoxia-induced EMT. TET1 knock-
down was performed in a H1299 lung cancer cell line.
Exposure of H1299 cells to hypoxia induced EMT as
characterized by repression of E-cadherin/plakoglobin
and upregulation of vimentin/N-cadherin expression
[5,6] (Figure 1e). Knockdown of TET1 abolished the
upregulation of mesenchymal gene expression includ-
ing vimentin and N-cadherin (Figure 1e). Immunofluor-
escence assays showed the no change of E-cadherin
expression and abolishment of vimentin upregulation in
H1299 cells under TET1 knockdown (Additional file 3a).
TET1 knockdown also significantly decreased the in vitro
migration and invasion activity induced by hypoxia in
H1299 cells (Additional file 3b). The same results were
obtained using the head and neck cancer FADU cell line
(Additional file 4). These results indicate that TET1 plays
a crucial role in hypoxia-induced EMT and induction of
in vitro migration/invasion activity.
Cholesterol metabolic process is regulated by TET1 and
knockdown of INSIG1 mitigates hypoxia-induced
epithelial-mesenchymal transition
Since TET1 demethylates 5mC to regulate gene expres-
sion [13,14], we wanted to determine the genes whose
expression was regulated by TET1 under hypoxia. RNA
sequencing experiments using FADU control vs. FADU-
TET1 knockdown cells under normoxia or hypoxia
showed that a total of 1,044 genes were regulated by
TET1 under hypoxia since their expression decreased
under TET1 knockdown (Figure 2a and b). Transcrip-
tome profiles were shown in Figure 2a. Gene Ontology
(GO) analysis of these genes showed that they belonged
to various biological processes (Additional file 5a). To
further narrow down the genes that were regulated by
TET1 and also showed changes in the levels of 5hmC in
their promoter regions, 5hmC sequencing was performed
on these FADU clones under normoxia or hypoxia (control
vs. TET1 knockdown) [19]. Analysis of 5hmC sequencing
results showed the distribution of 5hmC peaks (Additional
file 5b). There were no genome-wide changes of 5hmClabeling with regards to their genomic locations under nor-
moxia or hypoxia (Additional file 6a), indicating that
5hmC regulated by TET1 only influenced the expression
of certain specific genes. To search for genes that were reg-
ulated by TET1 from RNA expression analysis and also
had increased levels of 5hmC in their promoters, Venn dia-
gram showed that 98 genes had such patterns (Figure 2b).
GO analysis of the 98 genes categorized them into different
groups (Figure 2c). It is interesting that the genes belong-
ing to cholesterol metabolic process represented the most
statistically significant group (Figure 2c), which was also
one of the prominently represented groups from RNA-Seq
analysis (Additional file 5a). INSIG1 (insulin induced
gene 1), a major regulator of cholesterol biosynthesis
[20,21], was inside this group (Figure 2a and c). INSIG1
sequesters SREBP in ER to inhibit cholesterol synthesis
and promotes the degradation of HMG CoA reductase
[20,21]. We further focused on the analysis of INSIG1
gene since HIF-1α inhibits sterol regulatory element bind-
ing protein-1c (SREBP-1c) and suppresses excessive lipid
accumulation [22,23]. Analysis of INSIG1 RNA levels con-
firmed the activation of INSIG1 expression by hypoxia
and knockdown of TET1 decreased the expression of
INSIG1 under hypoxia in two different cell lines using
quantitative real-time PCR analysis (Figure 2d and e and
Additional file 6b and c).
Demethylation of the INSIG1 promoter regions by TET1
To correlate the RNA expression and 5hmC levels in the
promoter region regulated by TET1, the group of chol-
esterol metabolic process genes including INSIG1, FDPS
(farnesyl diphosphate synthase), APOC1 (apolipoprotein
C1), and SQLE (squalene epoxidase) were analyzed. There
were increased 5hmC peaks in their promoters (Figure 3a
and Additional file 7). Since the expression of INSIG1 was
confirmed (Figure 2d and e and Additional file 6b and c),
we further analyzed the 5hmC peaks in the promoter of
INSIG1. The 5hmC peaks in two different promoter re-
gions of INSIG1 gene were confirmed to be increased by
hypoxia and decreased under TET1 knockdown in two
different cell lines using hMeDIP assays (Figure 3b and
Additional file 8). In addition, the levels of 5mC also de-
creased in the promoter region of INSIG1 under hypoxia
in two different cell lines using MeDIP assays (Figure 3c
and Additional file 9). Finally, to test the role of INSIG1
in hypoxia-induced EMT, knockdown of INSIG1 was
performed. The result showed that knockdown of
INSIG1 abolished hypoxia-induced EMT in FADU and
H1299 cells, mainly abolishing mesenchymal gene acti-
vation (Figure 3d and Additional file 10a). Increased
in vitro migration and invasion activity in H1299 cells
induced by hypoxia was abolished under INSIG1 knock-
down (Additional file 10b). Further analysis showed that
the abolishment of hypoxia-induced EMT by knockdown
Figure 2 Cholesterol metabolic process was the major pathway regulated by hypoxia-induced TET1 and activation of INSIG1 expression by
hypoxia, which was abolished by TET1 knockdown using real-time PCR analysis. (a) Scatter plot comparing transcriptome profile of hypoxia
sample with scrambled knockdown vs. hypoxia sample with TET1 knockdown in FADU cell lines. Gene expression was measured by FPKM. The genes
with the fold change >2 or <0.5 were denoted as black dots. The 1,044 genes regulated by TET1 under hypoxia were highlighted by red dots. The
square dot indicating the INSIG1 gene was pointed out. (b) Venn diagram showed the overlapping group of genes (98) that had both differential RNA
expression and differential 5hmC-enriched promoter regions. (c) Gene Ontology analysis of the genes with differential 5hmC-enriched regions and
differential RNA expression. The top 10 enriched biological processes based on their P values were shown. Cholesterol metabolic process ranked the
most significant group of genes regulated according to RNA expression and 5hmC peak levels. (d) Activation of INSIG1 expression by hypoxia in
H1299 cells using real-time PCR analysis. N: normoxia; H: hypoxia. (e) Knockdown of TET1 abolished the activation of INSIG1 expression induced by
hypoxia in H1299 cells using real-time PCR analysis. The asterisk (*) indicates statistical significance (P <0.05) between experimental and control clones.
The H1299 vector or H1299 scrambled control clone under normoxia was chosen as the control condition in (d) and (e). Error bars indicate standard
deviations (s.d.) of duplicate mRNA levels by real-time PCR analysis (d,e).
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regulators including Twist1 and Snail (Additional file 10c).
All the above results indicate that INSIG1 plays a signifi-
cant role in hypoxia-induced EMT, which is regulated by
TET1.
Regulation of glucose metabolism gene expression by
TET1 or INSIG1
We tested whether TET1 or INSIG1 regulates glucose
metabolism pathway to possibly contribute to hypoxia-
induced Warburg effect [24,25]. The genes in the glucose
metabolism pathway were tested for their expression
under hypoxia and knockdown of TET1 or INSIG1. Theresults showed that the genes including glucose trans-
porter 3 (GLUT3), hexokinase 1 (HK1), phosphoglycer-
ate kinase 2 (PGK2), pyruvate kinase M (PKM), and
lactate dehydrogenase A (LDHA) were induced by hyp-
oxia and knockdown of TET1 or INSIG1 abolished or
decreased their expression levels in two different cell
lines (Figure 4a,b, and Additional file 11a,b). In con-
trast, phosphoglycerate kinase 1 (PGK1) was induced
by hypoxia but did not respond to TET1 or INSIG1
knockdown (Figure 4c,d and Additional file 11c,d).
These results indicate that TET1 and INSIG1 regulate
the expression of hypoxia-induced glycolytic genes and
may contribute to Warburg effect induced by hypoxia.
Figure 3 Localization of 5hmC peaks in the INSIG1 gene promoter by analysis of 5hmC sequencing, confirmation of the 5hmC peaks
by hMeDIP and MedIP analysis, and knockdown of INSIG1 mitigated the process of hypoxia-induced epithelial-mesenchymal transition.
(a) Visualization of 5hmC signal in the INSIG1 promoter. The y axis is normalized read counts. The regions analyzed for 5hmC and 5mC levels
(b,c) were labeled as dark brackets. (b) Confirmation of increased 5hmC peaks in the promoter region of INSIG1 gene using hMeDIP analysis. N;
normoxia; H: hypoxia. (c) Confirmation of decreased 5mC peak in the promoter of INSIG1 gene using MeDIP analysis. The asterisk (*) indicates
statistical significance (P <0.05) between experimental and control clones. The FADU scrambled control clone under normoxia was chosen as the
control condition in (b) and (c). Error bars indicate standard deviations (s.d.) of duplicate analysis by PCR (b,c). (d) Knockdown of INSIG1
mitigated hypoxia-induced epithelial-mesenchymal transition.
Tsai et al. Genome Biology 2014, 15:513 Page 5 of 13
http://genomebiology.com/2014/15/11/513TET1 acts as a transcription co-activator to regulate
hypoxia-induced gene expression
Since there were TET1-regulated genes that did not
show difference in the 5hmC levels in their promoters
(Figure 2b), we speculated that TET1 may serve as a co-
regulator together with HIFs to regulate gene expres-
sion. To test this hypothesis, reporter gene assays using
HIF-1α, TET1, CBP (CREB binding protein), and
Twist1 promoter-driven reporter construct were per-
formed in 293 T cells. Our previous results indicated
that wild-type HIF-1α could be stably expressed in
293 T cells due to the overexpression of HIF-1α that is
beyond the HIF-1α degradation activity under normoxia
[6,11]. Indeed TET1 further enhanced the reporter gene
activity similar to CBP (Figure 5a). In addition, the TET1
enzymatically inactive mutant (TET1-CDmt) also hadsimilar activity to increase the ability of HIF-1α to pro-
mote Twist1 promoter activity (Figure 5a) [26]. Similar re-
sults were shown using the WDR5 promoter-driven
reporter construct (Additional file 12a). In addition, using
the INSIG1 promoter-driven reporter gene, the ability of
HIF-2α to promote its activity was further enhanced by ei-
ther TET1 wild-type or TET1-CDmt protein (Additional
file 12b and c). These results indicate that TET1 may
serve as a co-activator to enhance the transactivation ac-
tivity of either HIF-1α or HIF-2α.
For TET1 to be a co-activator of HIFs, there should be
interaction between TET1 and HIFs. Co-immunoprecipitation
assays were performed by co-transfecting HIF-1α and
TET1 into 293 T cells. The results showed that the
anti-HIF-1α antibody pulled down both HIF-1α and
TET1 (Figure 5b). Reverse assays also showed that the
Figure 4 TET1 and INSIG1 regulated expression of glucose metabolism genes induced by hypoxia in H1299 cells. (a,b) Induction of
GLUT3, HK1, PGK2, PKM, and LDHA expression by hypoxia, which were regulated by TET1 and INSIG1. (c,d) Hypoxia-induced PGK1 expression was not
regulated by TET1 or INSIG1. The asterisk (*) indicates statistical significance (P <0.05) between experimental (hypoxia) and control (normoxia) clones.
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(Additional file 13a). HIF-1α also interacted with the
enzymatically inactive TET1 (TET1-CDmt) by co-
immunoprecipitation assays (Figure 5b and Additional
file 13a). The interaction also occurred between HIF-2α
and TET1 as well as between HIF-2α and TET1-CDmt
(Additional file 13b and c). To further map the domain in
HIF-1α that interacts with TET1, co-immunoprecipitation
assays using various truncation mutants of HIF-1α and
TET1 showed that the amino terminal domain (a.a. 1-400)
of HIF-1α interacted with TET1 (Additional file 14). Fur-
ther mapping experiments showed that the a.a. 175-305
region of HIF-1α interacted with TET1 (Figure 5c and
Additional file 15a and b). To map the domain in TET1
that has transactivation activity, a yeast one hybrid assay
was performed. The a.a. 451-674 region in TET1 displayed
transactivation activity in contrast to the other regions
that did not provide transactivation activity (Figure 5d).
Further dissection of the transactivation domain showed
that dividing this domain into two regions disrupted the
transactivation activity (Additional file 15c). All the above
results indicate that TET1 serves as a co-activator to inter-
act with HIFs and activate the expression of hypoxia
downstream targets.
Since O-linked N-glucosamine (O-GlcNAc) transfer-
ase (OGT) interacts with TET1 to modulate TET1
levels and regulate CpG island methylation [27,28], we
tested whether OGT could also interact with HIF-1αand TET1 to regulate HIF-1α target gene expression.
Co-immunoprecipitation experiments using an anti-TET1
antibody to pull down extracts from H1299 cells showed
that both HIF-1α and OGT can be pulled down by an
anti-TET1 antibody (Figure 5e), indicating that endogen-
ous TET1 interacts with HIF-1α and OGT. However, only
TET1 and CBP can be pulled down by an anti-HIF-1α
antibody, but not OGT (Additional file 16a). This result
suggested that there may not be direct interaction of HIF-
1α with OGT. Other co-immunoprecipitation experi-
ments showed that only TET1 can be pulled down by an
anti-OGT antibody, but not HIF-1α or CBP (Additional
file 16b). In addition, only HIF-1α can be pulled down by
an anti-CBP antibody, but not OGT or TET1 (Additional
file 16c). Co-expression of OGT with HIF-1α and CBP did
not further increase the HIF-1α target gene expression
using transient transfection assays (data not shown).
These results indicate that TET1 may form different com-
plexes with HIF-1α/CBP or OGT to regulate different tar-
get gene expression.
Rescue of hypoxia-induced EMT in TET1 knockdown cells
by a TET1 catalytically inactive mutant
Since TET1 knockdown mitigated hypoxia-induced EMT
and TET1 can act as a transcriptional co-activator without
the enzymatic activity, we tested whether a TET1 catalyt-
ically inactive mutant could rescue hypoxia-induced EMT
in TET1 knockdown cells. The TET1-CDmt expression
Figure 5 TET1 served as a co-activator to activate hypoxia downstream target and TET1 interacted with HIF-1α through a specific
domain together with mapping of the transactivation domain in TET1. (a) Synergistic activation of the Twist1-driven reporter construct by
co-transfecting HIF-1α, TET1 (wild-type or point mutant), and CBP. N: normoxia; H: hypoxia. The asterisk (*) indicates statistical significance (P <0.05)
between experimental and control transfections. pXP2-Twist1 promoter-driven luciferase construct alone was used as the control transfection. Error
bars indicate standard deviations (s.d.) of triplicate luciferase activity. (b) Co-immunoprecipitation assays showed the interaction between HIF-1α and
TET1. The expression levels of transfected proteins (WCE: whole cell extracts) were shown on the right panel. (c) Mapping of the domain in HIF-1α that
interacted with TET1. The HIF-1α-175-305 truncation mutant interacted with TET1 using the co-immunoprecipitation assays. (d) Yeast one hybrid assays
showed that the transactivation activity of TET1 is mapped to the region of a.a. 451-674. The HIF-1α (a.a. 1-826) was used as a positive control. The
yeasts transformed with different plasmids can survive in the Sc-Ura medium, whereas only the yeasts containing plasmids that can activate the HIS3
gene can survive in the selection medium of Sc-Ura-His. (e) Co-immunoprecipitation experiments showed that the anti-TET1 antibody pulled down
both endogenous OGT and HIF-1α in H1299 cells.
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down cell lines to test its ability to rescue hypoxia-induced
EMT. The results showed that TET1-CDmt was capable
of restoring hypoxia-induced EMT in two different TET1
knockdown cell lines (Figure 6a,b), indicating that the
catalytic activity of TET1 is dispensable for hypoxia-
induced EMT.
Conclusions
This report demonstrated that hypoxia-induced TET1 uses
another important mechanism by serving as a transcription
co-activator to regulate hypoxia-responsive gene expression
and EMT. It is interesting that INSIG1, the master regula-
tor of cholesterol biosynthesis [20,21], is involved in the
regulation of hypoxia-induced EMT, highlighting the nov-
elty and importance of lipid metabolism in regulating EMT
and metastasis. Due to the ability of INSIG1 to inhibit chol-
esterol biosynthesis [20,21] that may shun down lipid syn-
thesis to favor glucose utilization similar to the role of
AMPK that also inhibits cholesterol synthesis [29], the acti-
vation of INSIG1 expression through hypoxia-inducedTET1 may also contributes to Warburg effect observed
under hypoxia as supported by our results (Figure 4) [1,2].
It is interesting that INSIG1 did not regulate hypoxia-
induced EMT throughTwist1 or Snail, indicating that other
EMT regulators or mechanisms (for example, chromatin
modifiers) may be involved. Since we readily observed the
regulation of various glucose metabolic genes by INSIG1,
the cross talk between metabolism and other mechanisms
may explain the role of INISG1 in hypoxia-induced EMT.
Our results show that TET1 serves as a 5mC-specific
dioxygenase to mediate DNA demethylation of promoters
[10,11], while it also simultaneously interacts with tran-
scription factors as a co-activator to promote gene tran-
scription. This mechanism is a unique model of gene
transcription and a model is presented (Figure 6c). TET1
therefore represents a new class of co-activator compared
to the recent demonstration of PKM2 (pyruvate kinase
M2) as a HIF-1α co-activator [30]. The domain in TET1
that confers transactivation activity is mapped (a.a. 451-
674) by co-immunoprecipitation and yeast one-hybrid as-
says. It is interesting that this region contains the CXXC
Figure 6 Rescue of hypoxia-induced EMT in TET1 knockdown cells by a catalytically inactive TET1 mutant, and a model to depict the
discovery of this report. (a,b) Expression of the TET1-CDmt expression vector in FADU (a) or H1299 (b) cells with TET1 knockdown restored the
phenotype of hypoxia-induced EMT. (c) The model of TET1 serving as a 5mC dioxygenase and transcription activator. Red arrow indicates the
process of demethylation of 5mC by TET1. TAD: transactivation domain of HIF-1α; CXXC: CXXC domain of TET1 protein; CD: catalytic domain of
TET1 protein; meC: 5-methylcytosine; me: methyl group; HRE: hypoxia-response element.
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trast to the recruitment of TET1 by NANOG that requires
the catalytic activity of TET1 to establish pluripotency
[32], synergistic activation by TET1 and HIFs is independ-
ent of its enzymatic activity and supports that TET1 is a
bona fide transcription co-activator. Our results demon-
strate that TET1 plays a crucial role in the regulation of
hypoxia-responsive gene expression by acting as a tran-
scriptional co-activator since the catalytically inactive
TET1 could rescue hypoxia-induced EMT in TET1
knockdown cells. It is possible that TET1 also serves as a
co-repressor since Tet1 has dual functions on gene tran-
scription and also interacts with SIN3A [15,33]. Although
TET1 also interacts with OGT to regulate gene expression
[27,28], our results showed that TET1/OGT may form a
different complex from the HIF-1α/CBP/TET1 complex.
It will be important to search for other transcription fac-
tors that can interact with TET1 to regulate gene expres-
sion. Our results further expand the role of TET1 beyond
epigenetic regulation of gene expression.
Materials and methods
Cell culture
The cell lines used were described [6,11] including the
human hypopharyngeal squamous carcinoma cell lineFADU, human tongue squamous carcinoma cell line SAS,
and lung cancer cell lines H1299 and A549 (obtained from
ATCC). Human embryonic kidney 293 T cell line was
used in transient transfection experiments. SNU398 is a
human hepatoma cell line obtained from Dr. YS Jou
(Academia Sinica, Taiwan).
Protein extraction, western blot analysis, RNA extraction,
quantitative real-time PCR, in vitro migration/invasion
assay
For extraction of proteins from cell lines, cell lysis buffer
(50 mM Tris, pH 7.5, 150 mM NaCl, 0.5% sodium deoxy-
cholate, 1% NP-40, 0.1% SDS) containing protease inhibi-
tors was used. Cell lysates were clarified by centrifugation
at 13,000 rpm, 4°C for 10 min. The protein content was
determined by Bradford method (Bio-Rad Laboratories,
Hercules, CA, USA). For western blot analysis, 50 μg
to 100 μg protein extracts from each clone were loaded
to 10% SDS-PAGE gels and transferred to nitrocellulose
filters. The filters were probed with different antibodies
(Additional file 17), and an anti-ß-actin antibody was se-
lected as a loading control. Signals were developed using
an ECL chemiluminescence kit (Millipore Corporation,
Billerica, MA, USA). Total RNA was isolated using Trizol
reagent (Life Technologies Corporation, Carlsbad, CA,
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Single-stranded cDNA was synthesized by the RevertAid™
First Strand cDNA Synthesis Kit (Fermentas International,
Inc., Burlington, Canada). Real-time PCR was performed
on a StepOnePlus™ Real-Time PCR System (ABI: Applied
Biosystems, Foster City, CA USA) according to the manu-
facturer’s instructions. The 2-ΔΔCt method of relative
quantification was used to estimate the copy number of
gene expression, and 18S was selected as an internal con-
trol. The oligonucleotides used for real-time PCR were
shown in Additional file 18. For in vitro migration/inva-
sion assay, eight-μm pore size Boyden chamber was used.
Cells (4 × 104) in 0.5% serum-containing RPMI were
plated in the upper chamber and 15% fetal bovine serum
was added to RPMI 1640 in the lower chamber as a
chemo-attractant. For invasion assay, the upper side of the
filter was covered with Matrigel (BD Biosciences, San Jose,
CA, USA) (1:2 dilution with RPMI). After 12 h for migra-
tion assay or 24 h for invasion assay, cells on the upper
side of the filter were removed, and cells that remained
adherent to the underside of membrane were fixed in 4%
formaldehyde and stained with Hoechst 33342 dye. The
number of migrated cells was counted using a fluores-
cence microscope. Ten contiguous fields of each sample
were examined using a 40× objective to obtain a represen-
tative number of cells which migrated/invaded across the
membrane.
Plasmids, transfection, and luciferase assays
The plasmids used and transfection methods were de-
scribed using calcium phosphate or lipofection transfec-
tion method [6,11]. The expression vectors of HIF-1α,
HIF-2α, CBP, Twist1 promoter-driven luciferase con-
struct, and WDR5 promoter-driven luciferase construct
were described [6,11]. The TET1 and INSIG1 promoter
regions were cloned and the reporter constructs were
shown in Additional file 2. The oligonucleotides used for
plasmis constructions were shown in Additional file 19.
The reporter constructs were co-transfected into 293 T
cells with different expression vectors and an internal
control plasmid. Luciferase assays were performed using
the same amount of cell extracts and corrected for trans-
fection efficiency using an internal control (GFP) [6,11].
Quantitative chromatin immunoprecipitation (Chip)
ChIP assay was performed as described [6]. Briefly, cells
were cross-linked with 1% formaldehyde for 10 min and
stopped by adding glycine to a final concentration of
0.125 M. Fixed cells were washed twice with TBS
(20 mM Tris, pH 7.5, 150 mM NaCl) and harvested in
5 mL of SDS buffer (50 mM Tris, pH 8.0, 0.5% SDS,
100 mM NaCL, 5 mM EDTA, and protease inhibitors).
Cells were pelleted by centrifugation and suspended in
2 mL of IP buffer (100 mM Tris, pH 8.6, 0.3% SDS, 1.7%Triton X-100, 5 mM EDTA). Cells were sonicated with a
0.25-inch diameter probe for 15 s twice using an MSE-
soniprep 1500 sonicator (setting 18). For each immuno-
precipitation, 1 mL of lysate was precleared by adding
50 μL of blocked protein A beads (50% protein A-
Sepharose, Amersham Biosciences; 0.5 mg/mL bovine
serum albumin, 0.2 mg/mL salmon sperm DNA) at 4°C
for 1 h. Samples were spun, and the supernatants were
incubated at 4°C for overnight with no antibody, IgG,
anti-HIF-2α antibody. Immune complexes were recov-
ered by adding 50 μL of blocked protein A beads and
incubated overnight at 4°C. Beads were successively
washed with: (1) mixed micelle buffer (20 mM Tris,
pH 8.1, 150 mM NaCl, 5 mM EDTA, 5% w/v sucrose,
1% Triton X-100, 0.2% SDS); (2) buffer 500 (50 mM
Hepes, pH 7.5, 0.1% w/v deoxycholic acid, 1% Triton X-
100, 500 mM NaCl, 1 mM EDTA); (3) LiCl detergent
wash buffer (10 mM Tris, pH 8,0.5% deoxycholic acid,
0.5% Nonidet P-40, 250 mM LiCl, 1 mM EDTA); and (4)
TE buffer (10 mM Tris, 1 mM EDTA) and then eluted
with 1% SDS and 0.1 M NaHCO3. Twenty milliliters of
5 M NaCl was added to the elutes, and the mixture was
incubated at 65°C for 5 h to reverse the cross-linking.
After digestion with proteinase K, the solution was phe-
nol/chloroform-extracted and ethanol-precipitated. For
qChIP analysis [11], DNA fragments were resuspended
in 400 μL of water and 5 μL was used by real-time PCR.
Each sample was calculated as the percentage of input
sample. The sequences of PCR regions and primers used
in ChIP assay are listed (Additional file 20). The anti-
bodies used are listed (Additional file 17).
Immunofluorescence staining
For immunofluorescence staining [6,11], cells on glass
coverslips or chamber slides were fixed with 4% parafor-
maldehyde and permeabilized with 0.5% Triton X-100.
After washing three times for 10 min with PBS, fixed
cells or slides were blocked with blocking buffer (PBS,
0.1% Tween-20, with 3% goat serum) for 1 h and incu-
bated with primary antibody diluted in blocking buffer
overnight at 4°C. After washing three times with PBS for
10 min, the fixed cells were treated with the appropriate
secondary antibody (fluorescein isothiocyanate (FITC)-
conjugated anti-mouse IgG or rhodamine-conjugated
anti-rabbit IgG) (Sigma) that was diluted in blocking
buffer for 1 h at room temperature. Finally, the fixed cells
were washed three times for 10 min with TBS, and their
nuclei were counterstained, mounted, and observed by
using fluorescence microscope or confocal microscope.
Lentiviral infection
Lentivirus containing short hairpin RNAs (shRNAs)
expressed in a lentiviral vector (pLKO.1-puro) were
generated in 293 T cells as previously described [11].
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Teng (National Taiwan University, Taiwan). Various pLKO
plasmids to knockdown HIF-1α, HIF-2α, TET1, INSIG1,
and scrambled control were provided by National RNAi
Core Facility of Academia Sinica, Taipei, Taiwan. For
lentivirus production, 293 T cells were transfected with
15 μg pLKO.1-puro lentiviral vectors expressing differ-
ent shRNAs along with 1.5 μg of envelope plasmid
pMD.G and 15 μg of packaging plasmid pCMVΔR8.91.
Virus was collected 48 h after transfection. To prepare
various knockdown cells, FADU or H1299 cells were
infected with lentivirus for 24 h, and used for various
assays after 4 to 5 days. The sequence of the lentiviral
siRNA vectors were shown in Additional file 21.
RNA-Seq data analysis
The RNA-Seq libraries were prepared according to the
standard Illumina protocol with the mRNAseq Illumina
TruSeq and were sequenced using Illumina Hiseq2000 to
obtain 100 bp paired-end reads. The reads were aligned to
the hg19 reference assembly with the TopHat/Cufflinks
[34] alignment package using Ensembl annotations. Tran-
script abundance was measured in fragments per kb of
exon per million fragments mapped (FPKM).
5hmC chemical labeling
5hmC labeling reactions were performed according to
the previous protocol [35]. Briefly, sonicated genomic
DNA (average 400 bp, 500 ng/μL) was incubated with
50 mM HEPES buffer (pH 7.9), 25 mM MgCl2, 100 mM
UDP-6-N3-Glc, and 2 mM βGT for 1 h at 37°C. The la-
beled DNA was purified by the QIAquick Nucleotide
Removal kit (QIAGEN) and eluted in H2O. The click
chemistry was performed with the addition of 150 mM
of disulfide-biotin, and the mixture was incubated for
2 h at 37°C. The labeled DNA fragments were then puri-
fied by the QIAquick Nucleotide Removal kit (QIAGEN)
and enriched by Dynabeads Streptavidin C1 (Invitrogen),
and subsequently released by DTT treatment. The enriched
DNA fragments were first purified by Micro Bio-Spin 6
spin columns (Bio-Rad) followed by MinElute PCR Purifi-
cation Kit (QIAGEN).
5hmC-Seq data analysis
All the 5hmc-enriched DNAs were sequenced using Illu-
mina Hiseq2000 containing more than 2.5 × 107, 50 bp
single-end reads per sample. Raw sequence reads were
mapped onto the reference human genome (NCBI Build
UCSC hg19) using the Bowtie v0.12.7 algorithm (-m 1 -v
3 –best –strata) [36]. Unique and monoclonal reads
were used for further analysis. The distribution of 5hmC
reads at promoters or in gene body regions were analyzed
by PAVIS [37] (Additional file 6a). Further analysis wasdone using Bioconductor using packages ChIPpeakAnno,
biomaRt, MEDIPS and in-house scripts. The genes with
5hmC peaks at promoter region (approximately -3000 to
0 bp upstream of the transcription start site) were chosen
for further analysis.
Selection of overlapping groups of genes from RNA-Seq and
5hmC-Seq data followed by Gene Ontology (GO) analysis
The genes that have differential 5hmC-enriched pro-
moter regions from 5hmC-Seq analysis and are differen-
tially regulated from RNA-Seq analysis are selected for
functional enrichment analysis. For 5hmC-Seq data, the
criteria for genes with 5hmC-enriched promoter regions
are: the peak levels of Hypoxia (scrambled control) >4X
Hypoxia (TET1-si), Hypoxia (scrambled control) >2X
Normoxia (scrambled control), and Normoxia (scram-
bled control) >2X Normoxia (TET1-si). The differentially
expressed genes from RNA-Seq are identified by the cri-
teria: Hypoxia (scrambled control) >2X Hypoxia (TET1-si),
Hypoxia (scrambled control) > Normoxia (scrambled
control), and Normoxia (scrambled control) > or =Normoxia
(TET1-si). The 98 genes that were chosen through the
overlapping criteria by 5hmC-Seq and RNA-Seq ana-
lyses were further analyzed by GO-based functional en-
richment analysis. GO-based functional enrichment
analysis (Fisher’s Exact test) was used to measure the
gene-enrichment in annotation terms for selected
genes. The genes in the GO terms that passed the cri-
teria of P value <0.01 and at least two genes in each
GO term were considered for further analysis.
Detection of 5hmC levels within specific gene locus
(hMeDIP)
Genomic DNA was prepared using a genomic DNA
extraction kit (QIAGEN, Germany). Detection of 5-
hydroxymethylcytosine (5hmC) within specific gene locus
was performed by using EpiJET 5-hmC Analysis Kit
(Thermo Scientific, USA). The DNA was glucosylated and
digested with the Glc-5-hmC sensitive restriction endo-
nuclease Epi MspI. Glucosylation/digestion levels were an-
alyzed by qPCR. The sequences of oligonucleotides used
for hMeDIP were shown in Additional file 22.
Methylated DNA immunoprecipitation (MeDIP)
Genomic DNA was prepared using a genomic DNA ex-
traction kit (QIAGEN, Germany) and sonicated with
Bioruptor (Diagenode Inc., USA) to produce random
fragments ranging in mean size from 300 to 1,000 bp.
Two micrograms of fragmented DNA was denatured for
10 min at 95°C and immunoprecipitated for 16 h at 4°C
with 5 μL of 5-methylcytidine antibody (Eurogentec,
Germany) in a final volume of 250 μL IP buffer (20 mM
Tri-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA,
2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate,
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protein A beads for another 4 h at 4°C and washed three
times with 1 mL of IP buffer. Beads were resuspended with
500 μL digestion buffer (50 mM Tris (pH 8.0), 10 mM EDTA,
1% SDS) containing 10 μL proteinase K (20 mg/mL stock)
overnight at 65°C. DNA was phenol/chloroform-extracted,
ethanol-precipitated, and resuspended in 200 μL of water for
real-time PCR analysis. The sequences of oligonucleotides
used for MeDIP were shown in Additional file 22.
Yeast strains, transformations, and media
PJ69-4A (MATa trp1-901 leu2-3,112 ura3-52 his3-200
gal4Δ gal80Δ LYS2∷GAL1-HIS3 GAL2-ADE2 met2∷-
GAL7-lacZ) was used as the yeast strain. Media was pre-
pared as described [38]. All yeast transformations were
conducted using the high efficiency method described [39].
Co-immunoprecipitation assays
Co-immunoprecipitation was performed by incubating
antibody with 500 μL of whole cell extracts in IP buffer
(20 mM Tri-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA,
1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyro-
phosphate, 1 mM β-glycerophosphate, and protease in-
hibitor) with 50 μL of protein A/G mix magnetic beads
(Millipore) for 4 h at 4°C. The immunoprecipitates were
washed several times with IP buffer to removing any
non-bound proteins. Finally, components of the bound
immune complex are eluted, and then analyzed by west-
ern blot detection to verify the identity of proteins.
Measurement of transcriptional activation strength
The activation strength was measured by two different
assays which measure the expression of the reporter
genes: HIS3, which encodes imidazoleglycerol-phosphate
dehydratase and catalyzes the sixth step in yeast histi-
dine biosynthesis. The pGBDU constructs containing
HIF-1α, TET1, or TET1 truncation mutants were gener-
ated according to the length and restriction sites men-
tioned in Additional file 3. Plasmids were transformed
into the yeast strain PJ69-4A [40]. Transformed clones
were selected on SC-Ura plates and confirmed for HIS3
expression on SC-His plates. Five to 10 freshly trans-
formed colonies were mixed and spotted in five-fold ser-
ial dilutions onto plates. Plates were kept at 30°C until
colonies formed.
Statistical analysis
The independent Student’s t-test was used to compare the
continuous variables between two groups, and the χ2 test
was applied for comparison of dichotomous variables. The
control groups of all the statistical analyses were specified
in the figure legends. The level of statistical significance
was set at 0.05 for all tests.Accession number
Sequencing data have been deposited to the Gene Expres-
sion Omnibus (GEO) under accession number GSE59990.
Additional files
Additional file 1: Figure S1. Activation of TET1 expression by hypoxia
in various cell lines, knockdown of HIF-2α abolished the activation of
TET1 by hypoxia, and demonstration of HIF-2α binding to the promoter
regions of TET1 and WDR5 genes.
Additional file 2: Table S1. Information of plasmids for luciferase assay.
Additional file 3: Figure S2. Immunofluorescence staining of E-cadherin
and vimentin, and in vitro migration and invasion activity of H1299 cell lines
with scrambled or TET1 knockdown under normoxia or hypoxia.
Additional file 4: Figure S3. Knockdown of TET1 mitigated
hypoxia-induced epithelial-mesenchymal transition in FADU cells,
immunofluorescence staining of E-cadherin and vimentin, and in vitro
migration and invasion activity of FADU cell lines with scrambled or TET1
knockdown under normoxia or hypoxia.
Additional file 5: Figure S4. Gene Ontology analysis of the groups of
genes that showed differential expression from RNA-Seq analysis and the
global distribution of 5hmC peaks in FADU cells with scrambled or TET1
knockdown under normoxia or hypoxia.
Additional file 6: Figure S5. The percentage of distribution of 5hmC
peaks, activation of INSIG1 by hypoxia in FADU cells, and TET1 knockdown
abolished INSIG1 expression induced by hypoxia.
Additional file 7: Figure S6. Localization of 5hmC peaks in the FDPS (a),
APOC1 (b), and SQLE (c) gene promoters by analysis of 5hmC sequencing.
Additional file 8: Figure S7. 5hmC levels in the different promoter regions
of INSIG1 gene in H1299 cells or FADU cells under normoxia or hypoxia.
Additional file 9: Figure S8. The 5-methylcytosine (5mC) levels in the
promoter regions of INSIG1 gene in FADU cells or H1299 cells under
normoxia or hypoxia.
Additional file 10: Figure S9. Knockdown of INSIG1 mitigated
hypoxia-induced epithelial-mesenchymal transition in H1299 cells, and
the levels of Twist1 or Snail levels were not affected by INSIG1 knockdown
in FADU cells.
Additional file 11: Figure S10. Real-time PCR analysis of the expression
of various glycolytic enzymes (normoxia vs. hypoxia) under TET1 or INSIG1
knockdown.
Additional file 12: Figure S11. Synergistic activation of WDR5 or INSIG1
promoter by HIF-2α, TET1 (wild-type or point mutant), and CBP under
normoxia or hypoxia.
Additional file 13: Figure S12. Co-immunoprecipitation experiments
showed the interaction between TET1 and HIF-1α or HIF-2α.
Additional file 14: Figure S13. Mapping of the domain in HIF-1α that
interacted with TET1.
Additional file 15: Figure S14. Further mapping of the domain in
HIF-1α that interacted with TET1.
Additional file 16: Figure S15. Various co-immunoprecipitation
experiments to check the interaction between different proteins.
Additional file 17: Table S2. List of proteins tested by antibodies and
characteristics of the corresponding antibodies.
Additional file 18: Table S3. Sequence of the oligonucleotides for
real-time PCR.
Additional file 19: Table S4. Sequence of the oligonucleotides for
construct-making.
Additional file 20: Table S5. Sequence of the oligonucleotides for
ChIP analysis.
Additional file 21: Table S6. Sequence of the lentiviral siRNA vectors.
Additional file 22: Table S7. Sequence of the oligonucleotides for
5hmc assay and MeDIP.
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